Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Aurora, CO
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Atlanta, GA
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Detroit, MI
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Saint Louis, MO
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Durham, NC
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Cleveland, OH
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Charleston, SC
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Nashville, TN
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated:  8/1/2016
mi
from
Edmonton,
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients < 4 Months of Age
Status: Enrolling
Updated: 8/1/2016
mi
from
Edmonton,
Click here to add this to my saved trials
Effects of Transcranial Direct Current Stimulation (tDCS) and Visual Illusion on Chronic Pain Due to Spinal Cord Injury
Investigation of the Mechanisms of Transcranial Direct Current Stimulation of Motor Cortex Coupled With Visual Illusion for the Treatment of Chronic Pain in Spinal Cord Injury
Status: Enrolling
Updated:  8/1/2016
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Effects of Transcranial Direct Current Stimulation (tDCS) and Visual Illusion on Chronic Pain Due to Spinal Cord Injury
Investigation of the Mechanisms of Transcranial Direct Current Stimulation of Motor Cortex Coupled With Visual Illusion for the Treatment of Chronic Pain in Spinal Cord Injury
Status: Enrolling
Updated: 8/1/2016
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Emergency Physician Brief Interventions for Alcohol
Emergency Physician Brief Interventions for Alcohol
Status: Enrolling
Updated:  8/4/2016
Yale University
mi
from
New Haven, CT
Emergency Physician Brief Interventions for Alcohol
Emergency Physician Brief Interventions for Alcohol
Status: Enrolling
Updated: 8/4/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Center for Innovation in Restorative Medicine
mi
from
Pittsburgh, PA
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Center for Innovation in Restorative Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Division of Burns and Trauma, Jackson Memorial Hospital
mi
from
Miami, FL
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Division of Burns and Trauma, Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Lehigh Valley Health Network
mi
from
Allentown, PA
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Long Island Plastic Surgical Group
mi
from
Garden City, NY
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Long Island Plastic Surgical Group
mi
from
Garden City, NY
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Loyola University Medical Center
mi
from
Maywood, IL
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Richard M. Fairbanks Burn Center
mi
from
Indianapolis, IN
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Richard M. Fairbanks Burn Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
Univ of California David Medical Center
mi
from
Sacramento, CA
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
Univ of California David Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated:  8/8/2016
University of California, San Diego
mi
from
San Diego, CA
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
Status: Enrolling
Updated: 8/8/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells
A Randomized Prospective Double - Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
Status: Enrolling
Updated:  8/8/2016
University of Pittsburgh UPMC Eye Center
mi
from
Pittsburgh, PA
Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells
A Randomized Prospective Double - Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
Status: Enrolling
Updated: 8/8/2016
University of Pittsburgh UPMC Eye Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Combined Ketamine/Propofol for Emergency Department Procedural Sedation
Combined Ketamine/Propofol for Emergency Department Procedural Sedation
Status: Enrolling
Updated:  8/8/2016
University of Missouri - Columbia dept. of Emergency Medicine
mi
from
Columbia, MO
Combined Ketamine/Propofol for Emergency Department Procedural Sedation
Combined Ketamine/Propofol for Emergency Department Procedural Sedation
Status: Enrolling
Updated: 8/8/2016
University of Missouri - Columbia dept. of Emergency Medicine
mi
from
Columbia, MO
Click here to add this to my saved trials
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated:  8/10/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated: 8/10/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated:  8/10/2016
Duke University
mi
from
Durham, NC
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated: 8/10/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated:  8/10/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated: 8/10/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated:  8/10/2016
Univ of Washington
mi
from
Seattle, WA
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Improving Decision Making for Patients With Prolonged Mechanical Ventilation
Status: Enrolling
Updated: 8/10/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation
Status: Enrolling
Updated:  8/18/2016
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
mi
from
Cleveland, OH
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation
Status: Enrolling
Updated: 8/18/2016
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation
Status: Enrolling
Updated:  8/18/2016
Anaheim Clinical Trials - Phase I Clinical Pharmacology Unit
mi
from
Anaheim, CA
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation
Status: Enrolling
Updated: 8/18/2016
Anaheim Clinical Trials - Phase I Clinical Pharmacology Unit
mi
from
Anaheim, CA
Click here to add this to my saved trials
Diagnostic Breath Analysis Study to Detect Sepsis
Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Systemic Inflammatory Response Syndrome (SIRS) and Sepsis
Status: Enrolling
Updated:  9/7/2016
Ventura County Medical Center
mi
from
Ventura, CA
Diagnostic Breath Analysis Study to Detect Sepsis
Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Systemic Inflammatory Response Syndrome (SIRS) and Sepsis
Status: Enrolling
Updated: 9/7/2016
Ventura County Medical Center
mi
from
Ventura, CA
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
UT Southwestern Medical Center
mi
from
Dallas, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated:  9/28/2016
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Continuous Glucose Monitoring in Critically Ill
Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU
Status: Enrolling
Updated: 9/28/2016
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Brain Training to Enhance Frontal Lobe Reasoning
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated:  10/24/2016
Center for BrainHealth
mi
from
Dallas, TX
Brain Training to Enhance Frontal Lobe Reasoning
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated: 10/24/2016
Center for BrainHealth
mi
from
Dallas, TX
Click here to add this to my saved trials
The Cooling And Surviving Septic Shock Study (CASS)
Randomized Trial to Determine Whether Mild Induced Hypothermia Can Reduce Mortality in Adult Patients With Septic Shock
Status: Enrolling
Updated:  11/21/2016
Cleveland Clinic - Outcomes Research
mi
from
Cleveland, OH
The Cooling And Surviving Septic Shock Study (CASS)
Randomized Trial to Determine Whether Mild Induced Hypothermia Can Reduce Mortality in Adult Patients With Septic Shock
Status: Enrolling
Updated: 11/21/2016
Cleveland Clinic - Outcomes Research
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Cooling And Surviving Septic Shock Study (CASS)
Randomized Trial to Determine Whether Mild Induced Hypothermia Can Reduce Mortality in Adult Patients With Septic Shock
Status: Enrolling
Updated:  11/21/2016
Bispebjerg Hospital
mi
from
Copenhagen,
The Cooling And Surviving Septic Shock Study (CASS)
Randomized Trial to Determine Whether Mild Induced Hypothermia Can Reduce Mortality in Adult Patients With Septic Shock
Status: Enrolling
Updated: 11/21/2016
Bispebjerg Hospital
mi
from
Copenhagen,
Click here to add this to my saved trials
Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants
Status: Enrolling
Updated:  11/28/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants
Status: Enrolling
Updated: 11/28/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)
Obesity/Overweight in Persons With Early and Chronic SCI: A Randomized Multi-Center Controlled Lifestyle Intervention
Status: Enrolling
Updated:  11/29/2016
University of Miami
mi
from
Miami, FL
Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)
Obesity/Overweight in Persons With Early and Chronic SCI: A Randomized Multi-Center Controlled Lifestyle Intervention
Status: Enrolling
Updated: 11/29/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study of ACCS (Amnion-derived Cellular Cytokine Solution) in Diabetic Subjects With Deep Burns Managed With Skin Grafts
A Phase 2a Randomized, Double Blind, Placebo Controlled, Single-center Study of ACCS (Amnion-derived Cellular Cytokine Solution) Spray in Diabetic Subjects With Deep Burns Managed With Meshed Skin Grafts.
Status: Enrolling
Updated:  11/29/2016
The Burn Unit of the Wexner Medical Center at The Ohio State University.
mi
from
Columbus, OH
Study of ACCS (Amnion-derived Cellular Cytokine Solution) in Diabetic Subjects With Deep Burns Managed With Skin Grafts
A Phase 2a Randomized, Double Blind, Placebo Controlled, Single-center Study of ACCS (Amnion-derived Cellular Cytokine Solution) Spray in Diabetic Subjects With Deep Burns Managed With Meshed Skin Grafts.
Status: Enrolling
Updated: 11/29/2016
The Burn Unit of the Wexner Medical Center at The Ohio State University.
mi
from
Columbus, OH
Click here to add this to my saved trials
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Status: Enrolling
Updated:  11/30/2016
MGH
mi
from
Boston, MA
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Status: Enrolling
Updated: 11/30/2016
MGH
mi
from
Boston, MA
Click here to add this to my saved trials
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
A Pilot Randomized Control Trial of Advanced Supply of Levonorgestrel Emergency Contraception vs. Routine Postpartum Contraceptive Care in the Teenage Population
Status: Enrolling
Updated:  12/1/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
A Pilot Randomized Control Trial of Advanced Supply of Levonorgestrel Emergency Contraception vs. Routine Postpartum Contraceptive Care in the Teenage Population
Status: Enrolling
Updated: 12/1/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion
Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion
Status: Enrolling
Updated:  12/5/2016
CHMC
mi
from
Los Angeles, CA
Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion
Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion
Status: Enrolling
Updated: 12/5/2016
CHMC
mi
from
Los Angeles, CA
Click here to add this to my saved trials